MDA (malondialdehyde) modified Apolipoprotein B (ApoB) antigen 1015

$578.00 – $926.00

Antibody summary

Rabbit polyclonal to MDA ApoB
Suitable for: WB,IP
Reacts with: Hu MDA ApoB
Isotype:
0.5 mg, 1 mg

available sizes

Clear

SKU: 1015parent Categories: antibody, oxidative stress Tags: ApoB, MDA

Weight	1 lbs
Dimensions	9 × 5 × 2 in
concentration	1 mg/mL
applications	IP, WB
reactivity	MDA ApoB, protein
available sizes	0.5 mg, 1 mg

mdaapob antigen 1015

kit
Storage Store at -20°C
Form liquid

(APOB)

target relevance
Organism Homo sapiens (Human)
Protein names Apolipoprotein B-100 (Apo B-100) [Cleaved into: Apolipoprotein B-48 (Apo B-48)]
Gene names APOB
Mass 515545 Da
Function Apolipoprotein B is a major protein constituent of chylomicrons (apo B-48), LDL (apo B-100) and VLDL (apo B-100). Apo B-100 functions as a recognition signal for the cellular binding and internalization of LDL particles by the apoB/E receptor.
Subcellular location Cytoplasm. Secreted. Lipid droplet .
Structure and strains Interacts with PCSK9 (PubMed:22580899). Interacts with MTTP (PubMed:26224785, PubMed:27206948). Interacts with AUP1 (PubMed:28183703). Interacts with CIDEB (By similarity).
Post-translational modification Palmitoylated; structural requirement for proper assembly of the hydrophobic core of the lipoprotein particle.
Disease DISEASE: Hypobetalipoproteinemia, familial, 1 (FHBL1) [MIM:615558]: A disorder of lipid metabolism characterized by less than 5th percentile age- and sex-specific levels of low density lipoproteins, and dietary fat malabsorption. Clinical presentation may vary from no symptoms to severe gastrointestinal and neurological dysfunction similar to abetalipoproteinemia. Note=The disease is caused by variants affecting the gene represented in this entry. Most cases of FHBL1 result from nonsense mutations in the APOB gene that lead to a premature stop codon, which generate prematurely truncated apo B protein products (PubMed:21981844).; DISEASE: Hypercholesterolemia, familial, 2 (FHCL2) [MIM:144010]: A form of hypercholesterolemia, a disorder of lipoprotein metabolism characterized by elevated serum low-density lipoprotein (LDL) cholesterol levels, which result in excess deposition of cholesterol in tissues and leads to xanthelasma, xanthomas, accelerated atherosclerosis and increased risk of premature coronary heart disease. FHCL2 inheritance is autosomal dominant. Note=The disease is caused by variants affecting the gene represented in this entry.; DISEASE: Note=Defects in APOB associated with defects in other genes (polygenic) can contribute to hypocholesterolemia.
Target Relevance information above includes information from UniProt accession: P04114
The UniProt Consortium

Data

No results found

Publications

pmid	title	authors	citation
We haven't added any publications to our database yet.

Published literature highly relevant to the biological target of this product and referencing this antibody or clone are retrieved from PubMed database provided by The United States National Library of Medicine at the National Institutes of Health.